Actively Recruiting
Effectiveness of Musicotherapy in Reducing Pain Induced by Leg Ulcer Care
Led by University Hospital Center of Martinique · Updated on 2025-03-31
180
Participants Needed
1
Research Sites
86 weeks
Total Duration
On this page
Sponsors
U
University Hospital Center of Martinique
Lead Sponsor
M
Music Care
Collaborating Sponsor
AI-Summary
What this Trial Is About
Venous leg ulcer is the final stage of chronic venous disease and only develops due to advanced chronic venous insufficiency. The problems caused by venous disease are initially minor and often neglected, but can impact the quality of life of patients. The prevalence of leg ulcers is estimated at 1% of the general population and 3% to 5% of subjects over 65 years old. Its prevalence increases with age in both men and women. Managing chronic ulcers requires a certain number of care procedures, including debridement. The act of treatment by mechanical debridement is little relieved by the analgesics given beforehand, and can be painful, with risks of bleeding. Musicotherapy, particularly the U-shaped method, has shown its effectiveness in the treatment of pain and anxiety in several areas (geriatrics, intensive care, rheumatology, oncology, etc.). The standardized musicotherapy method of the U-shaped sequence was developed and initially evaluated by clinical studies coordinated by the INSERM unit U1061 (Pr. Jacques Touchon; Dr. Stéphane Guétin). Following the publication of numerous controlled, randomized studies presenting results on the effectiveness in the treatment of pain and anxiety, a digital application was developed in order to standardize the method. The Music Care health application is now a Class 1 Medical Device, with CE marking obtained. This "U-shaped sequence" is standardized and has been clinically validated, which makes Music Care a unique tool available for pain relief. No studies have been found in the literature regarding the use of music therapy during debridement care.
CONDITIONS
Official Title
Effectiveness of Musicotherapy in Reducing Pain Induced by Leg Ulcer Care
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patient
- Patient followed at the M@diCICAT healing center requiring wound debridement for a venous or arterial ulcer or necrotizing angiodermatitis of the lower limbs
- Ability to verbalize about their pain
- Planned debridement time less than 40 minutes
- Patient affiliated to or beneficiary of a social security scheme
- Patient having given free, informed and express consent
You will not qualify if you...
- Patient with a diabetic foot (loss of sensitivity-neuropathy)
- Patient not requiring a debridement session
- Patient with an infected ulcer (abscess, etc.)
- Patient with critical ischemia
- Patient with hearing problems
- Patient with cognitive disorders
- Patient placed under legal protection, guardianship or curatorship
- Pregnant or breastfeeding woman
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Center of Martinique
Fort-de-France, France, 97261
Actively Recruiting
Research Team
E
Emmanuelle Guitteaud
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here